4.9. PD-1/PD-L1 Blockade Bioassay

MM Michał Mikitiuk
JB Jan Barczyński
PB Przemysław Bielski
MA Marcelino Arciniega
UT Urszula Tyrcha
AH Aleksandra Hec
AL Andrea D. Lipińska
MR Michał Rychłowski
TH Tad A. Holak
TS Tomasz Sitar
request Request a Protocol
ask Ask a question
Favorite

The PD-1/PD-L1 immune checkpoint bioassay (PD-1/PD-L1 Bioassay, Promega) was performed according to the manufacturer’s manual. PD-L1 + aAPC/CHO-K1 cells were plated in 96-well, white, flat bottom assay plates at 40 × 104 cells in 100 µL of medium (Ham’s F12, 10% FBS) and incubated overnight at 37 °C, 5% CO2. The next day, the medium was removed from the assay plate, and serially diluted antibodies were added at 40 µL per well in the assay buffer (RPMI1640 + 1% FBS + 1% DMSO). Next, PD-1 Effector Jurkat cells (included in the assay kit) were resuspended in assay buffer (RPMI 1640 + 1% FBS) at a concentration of 1.25 × 106 cells/mL and added to the assay plate at 40 µL per well (total of 50 × 104 cells). The cells were co-cultured for 6 h (37 °C, 5% CO2) and then removed from the incubator and equilibrated at room temperature for 5 min. Bio-GloTM Reagent (Promega) was prepared according to the manufacturer’s manual and added to each well at 80 µL per well. Assay plates were incubated in room temperature for 15 min; luminescence was measured on the Tecan Spark microplate reader. Data were analyzed in GraphPad Prism software (v.9.5.1) using a log(inhibitor) vs. response—Variable slope (four parameters) model.

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A